Jennifer L Hoover

7PUBLICATIONS
15CO-AUTHORS
Medical infection agents (incl. prions)Nutritional epidemiologyPharmacogenomicsEpigenetics (incl. genome methylation and epigenomics)Immunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jan 03, 2022
Dose Selection for Phase III Clinical Evaluation of Gepotidacin (GSK2140944) in the Treatment of Uncomplicated Urinary Tract Infections.

Nicole E Scangarella-Oman, Mohammad Hossain, Jennifer L Hoover

|May 08, 2019
Efficacy of Human Exposures of Gepotidacin (GSK2140944) against Escherichia coli in a Rat Pyelonephritis Model.

Jennifer L Hoover, Christine M Singley, Philippa Elefante

|Mar 06, 2019
Generating Robust and Informative Nonclinical In Vitro and In Vivo Bacterial Infection Model Efficacy Data To Support Translation to Humans.

Jürgen B Bulitta, William W Hope, Ann E Eakin

|Aug 16, 2017
Reducing Antibacterial Development Risk for GSK1322322 by Exploring Potential Human Dose Regimens in Nonclinical Efficacy Studies Using Immunocompetent Rats.

Jennifer L Hoover, Christine M Singley, Philippa Elefante

Pageof 2